During December 2003 and March 2004, South Korea had experienced an epidemic of highly pathogenic avian influenza (HPAI) caused by a type A influenza virus of the H5N1 subtype. A total of 19 domestic poultry farms, ten chicken farms and nine duck farms were infected with the virus. Control measures included the depopulation of all poultry within 3-km-radius protection zone (stamping out), quarantines, disinfection, movement restrictions and surveillance. Approximately 5 million chickens and ducks were slaughtered and buried. At that time, the use of vaccines in such emergencies was limited in South Korea. The main reasons for vaccination bans were that vaccine-induced antibodies could interfere serologic surveillance and epidemiological studies.
Influenza vaccination has been widely practiced to reduce the incidence of clinical disease in poultry and, in some cases, has been used as part of an avian influenza eradication strategy. Recently the vaccination of HPAI in poultry has been increasing in China, Italy, Mexico, Pakistan and other countries. Differentiation of infected from vaccinated animals (DIVA) strategies have been proposed to overcome the impediment of avian influenza (AI) vaccination There is a possibility of the risk of re-entry of H5N1 HPAI to South Korea due to the recent Asian H5N1 epizootic outbreak. Because the use of highly pathogenic H5N1 strains has safety restrictions, the H5N3 virus with heterologous neuraminidase capable of evoking cross-reactive immunity to the H5N1 HPAI virus was investigated. Vaccination seems to remain the principal means of combating pandemic influenza.
Protection efficacy of both vaccines was evaluated by clinical signs, mortality rates and virus shedding from oropharynx and cloaca of vaccinated chickens after challenge with HPAI A/CK/Korea/ES/03 (H5N1) virus. One dose of 128HA homologous H5N1 vaccine induced 100% protection in mortality and prevented viral shedding completely after a lethal dose virus challenge, whereas one dose of 64HA unit heterologous H5N3 vaccine only induced 50% protection in mortality and did not prevent viral shedding. However, two doses of 64 HA unit heterologous H5N3 vaccine at 3-week intervals as well as one dose of 1024 HA unit heterologous H5N3 vaccine induced 100% survival rate and could prevent viral shedding completely. Further, researchers could differentiate the sera of infected birds from vaccinated ones by an indirect immunofluorescent antibody test. These results suggest that heterologous neuraminidase H5N3 vaccine could be a useful tool for the control of H5N1 HPAI epidemic in poultry. Summarized from Avian Diseases, Vol. 51, No. 1 Suppl., 2007, Pages 476-478 
